0

Patients With Melanoma In Situ Have Increased, But Low, Risk for Mortality

Patients With Melanoma In Situ Have Increased, But Low, Risk for Mortality

Patients With Melanoma In Situ Have Increased, But Low, Risk for Mortality

By July 25, 2024

Patients With Melanoma In Situ Have Increased, But Low, Risk for Mortality

Patients With Melanoma In Situ Have Increased, But Low, Risk for Mortality

Current Status
Not Enrolled
Price
Free
Get Started

This course discusses that melanoma in situ (MIS) is not a definite precursor to invasive melanoma. While a patient’s chance of dying from melanoma is elevated (albeit low in absolute terms), their overall survival is significantly higher than that of their peers without MIS.

Click CE Information to start the course. Post Test and Evaluation must be completed to earn certificate of completion.